SCHEMBL25899266

SCHEMBL25899266

CCc1cnc(N)c2c1cnn2C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PI4KA P42356 1/20 0.42
▸ PI4K2B Q8TCG2 1/20 0.42
▸ PI4K2A Q9BTU6 1/20 0.42
▸ PI4KB Q9UBF8 1/20 0.42
▸ LMNA P02545 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ NOS3 P29474 1/20 0.37
▸ NOS1 P29475 1/20 0.37
▸ NOS2 P35228 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ DHFR P00374 3/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25919989 0.77 PI4KA (0.40) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL25899012 0.77 PI4KA (0.46) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL25320775 0.75 PI4KA (0.44) PI4KAPI4K2BPI4K2API4KBHTT
SCHEMBL25899217 0.74 PI4KA (0.43) PI4KAPI4K2BPI4K2API4KBALDH1A1
SCHEMBL30886293 0.71 PI4KA (0.52) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL25320978 0.68 PI4KA (0.49) PI4KAPI4K2BPI4K2API4KBHTT
SCHEMBL25322907 0.68 PI4KA (0.38) PI4KAPI4K2BPI4K2API4KBHTT
SCHEMBL6611653 0.67 — —
SCHEMBL11611405 0.67 KDM4E (0.43) PI4KAPI4K2BPI4K2API4KBHPGD
SCHEMBL16158028 0.66 LMNA (0.40) LMNAHPGDMAPK1HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146990-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
WO-2023146991-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
WO-2023146987-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback